All news articles for July 2020

NPA Fabricant on CBD, NDIs, FDA resuming inspections

NPA Fabricant on CBD, NDIs, FDA resuming inspections

By Stephen Daniells

FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.

© eskymaks / Getty Images

Ashwagandha extract cuts amount of non-restorative sleep: RCT

By Stephen Daniells

Daily supplementation with a standardized ashwagandha extract (Shoden) may reduce the amount of nonrestorative sleep experienced by healthy adults, says data from a gold-standard randomized, double blind, placebo-controlled trial.

© Motortion / Getty Images

Pharmactive launches AffronEYE for esports, gamers

By Stephen Daniells

Spain-based Pharmactive Biotech Products has launched a proprietary saffron ingredient called affronEYE to potentially address the negative impacts of blue-light exposure.

Follow us

Products

View more

Webinars